Aðferð til hömlunar á beinuppsogi

Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOHN A. YATES, ANASTASIA G. DAIFOTIS, ARTHUR C. SANTORA II
Format: Patent
Sprache:ice
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JOHN A. YATES
ANASTASIA G. DAIFOTIS
ARTHUR C. SANTORA II
description Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IS7231A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IS7231A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IS7231A3</originalsourceid><addsrcrecordid>eNrjZFB1PLwhLbXo8AaFkswchYzD23JzSvMSixQOL1RISs3MKy0oKM5Pz-RhYE1LzClO5YXS3Awybq4hzh66qQX58anFBYnJqXmpJfGeweZGxoaOxgSkAdNbJ7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Aðferð til hömlunar á beinuppsogi</title><source>esp@cenet</source><creator>JOHN A. YATES ; ANASTASIA G. DAIFOTIS ; ARTHUR C. SANTORA II</creator><creatorcontrib>JOHN A. YATES ; ANASTASIA G. DAIFOTIS ; ARTHUR C. SANTORA II</creatorcontrib><description>Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.</description><edition>7</edition><language>ice</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040421&amp;DB=EPODOC&amp;CC=IS&amp;NR=7231A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040421&amp;DB=EPODOC&amp;CC=IS&amp;NR=7231A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHN A. YATES</creatorcontrib><creatorcontrib>ANASTASIA G. DAIFOTIS</creatorcontrib><creatorcontrib>ARTHUR C. SANTORA II</creatorcontrib><title>Aðferð til hömlunar á beinuppsogi</title><description>Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB1PLwhLbXo8AaFkswchYzD23JzSvMSixQOL1RISs3MKy0oKM5Pz-RhYE1LzClO5YXS3Awybq4hzh66qQX58anFBYnJqXmpJfGeweZGxoaOxgSkAdNbJ7g</recordid><startdate>20040421</startdate><enddate>20040421</enddate><creator>JOHN A. YATES</creator><creator>ANASTASIA G. DAIFOTIS</creator><creator>ARTHUR C. SANTORA II</creator><scope>EVB</scope></search><sort><creationdate>20040421</creationdate><title>Aðferð til hömlunar á beinuppsogi</title><author>JOHN A. YATES ; ANASTASIA G. DAIFOTIS ; ARTHUR C. SANTORA II</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IS7231A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ice</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHN A. YATES</creatorcontrib><creatorcontrib>ANASTASIA G. DAIFOTIS</creatorcontrib><creatorcontrib>ARTHUR C. SANTORA II</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHN A. YATES</au><au>ANASTASIA G. DAIFOTIS</au><au>ARTHUR C. SANTORA II</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Aðferð til hömlunar á beinuppsogi</title><date>2004-04-21</date><risdate>2004</risdate><abstract>Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ice
recordid cdi_epo_espacenet_IS7231A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Aðferð til hömlunar á beinuppsogi
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T18%3A04%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHN%20A.%20YATES&rft.date=2004-04-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIS7231A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true